Discontinued Product

N-Desmethylclozapine (Cat. No. 1007) has been withdrawn from sale for commercial reasons.
Description: 5-HT2C antagonist
Alternative Names: Normethylclozapine, Norclozapine
Chemical Name: 8-Chloro-11-(1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
Purity: ≥99% (HPLC)
Citations (3)
Literature (3)

Biological Activity for N-Desmethylclozapine

N-Desmethylclozapine is an a major metabolite of clozapine; a potent and selective 5-HT2C serotonin receptor antagonist.

Technical Data for N-Desmethylclozapine

M. Wt 312.8
Formula C17H17ClN4
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 6104-71-8
PubChem ID 210172
Smiles ClC1=CC=C2NC3=C(C=CC=C3)C(=NC2=C1)N1CCNCC1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for N-Desmethylclozapine

Certificate of Analysis / Product Datasheet
Select another batch:

References for N-Desmethylclozapine

References are publications that support the biological activity of the product.

Fox and Brotchie (1996) Normethylclozapine potentiates the action of quinpirole in the 6-hydroxyDA lesioned rat. Eur.J.Pharmacol. 301 27 PMID: 8773443

Kuoppamäki et al (1993) Clozapine and methylclozapine are potent 5-HT1C receptor antagonists. Eur.J.Pharmacol. 245 179 PMID: 8387927

Wong et al (1996) Effects of cloz. metabolites and chronic cloz. treatment on rat brain GABAA receptors. Eur.J.Pharmacol. 314 319 PMID: 8957253

View Related Products by Target

View Related Products by Product Action

View all 5-HT2C Receptor Antagonists

Keywords: N-Desmethylclozapine, N-Desmethylclozapine supplier, 5-HT2C, antagonists, Serotonin, Receptors, Norclozapine, Normethylclozapine, 1007, Tocris Bioscience

3 Citations for N-Desmethylclozapine

Citations are publications that use Tocris products. Selected citations for N-Desmethylclozapine include:

Magliaro and Saldanha (2009) Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation. Brain Res 1283 14 PMID: 19501068

Sur et al (2003) N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-MthD.-aspartate receptor activity. Proc Natl Acad Sci U S A 100 13674 PMID: 14595031

Gregory et al (2010) Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias. J Biol Chem 285 7459 PMID: 20051519

Reviews for N-Desmethylclozapine

There are currently no reviews for this product. Be the first to review N-Desmethylclozapine and earn rewards!

Have you used N-Desmethylclozapine?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

5-HT Receptors Scientific Review

5-HT Receptors Scientific Review

Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.